Cell harvesting is crucial to the cell therapy manufacturing process, bridging the gap between cells’ optimized growth environment and a final formulation that retains their potency and efficacy. The number of variables that impact harvesting, coupled with the complexities introduced by the unique CQAs of each cell therapy and the fragility of many emerging cell types, can result in a challenging balancing act that requires significant expertise to navigate.
Lentiviral vectors are commonly used in the production of ex vivo cell therapies to transduce various cell types. Lentiviral vectors are sensitive to the shear forces of traditional continuous centrifugation systems. Additionally, significant yield losses due to adsorption effects can be seen during the primary clarification of lentiviral vectors with single-use filtration methods such as depth filtration.
Single-use equipment has become universally accepted and used for the manufacturing of clinical and licensed drug products. Download this whitepaper and learn more about the benefits of single-use technologies, and the important features to provide fast processing times, low-shear performance and high product recovery in a scalable platform.
Back to All Publications
Get in touch with a sales representative, request support or download our free white paper.